NM_001134363.3:c.3452-9C>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001134363.3(RBM20):c.3452-9C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00545 in 1,548,570 control chromosomes in the GnomAD database, including 412 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.029 ( 194 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 218 hom. )
Consequence
RBM20
NM_001134363.3 intron
NM_001134363.3 intron
Scores
1
Clinical Significance
Conservation
PhyloP100: -0.230
Publications
5 publications found
Genes affected
RBM20 (HGNC:27424): (RNA binding motif protein 20) This gene encodes a protein that binds RNA and regulates splicing. Mutations in this gene have been associated with familial dilated cardiomyopathy. [provided by RefSeq, Apr 2014]
RBM20 Gene-Disease associations (from GenCC):
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1DDInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 10-110831052-C-G is Benign according to our data. Variant chr10-110831052-C-G is described in ClinVar as Benign. ClinVar VariationId is 3894996.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0972 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RBM20 | NM_001134363.3 | c.3452-9C>G | intron_variant | Intron 12 of 13 | ENST00000369519.4 | NP_001127835.2 | ||
| RBM20 | XM_017016103.3 | c.3287-9C>G | intron_variant | Intron 12 of 13 | XP_016871592.1 | |||
| RBM20 | XM_017016104.3 | c.3068-9C>G | intron_variant | Intron 12 of 13 | XP_016871593.1 | |||
| RBM20 | XM_047425116.1 | c.3068-9C>G | intron_variant | Intron 12 of 13 | XP_047281072.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RBM20 | ENST00000369519.4 | c.3452-9C>G | intron_variant | Intron 12 of 13 | 1 | NM_001134363.3 | ENSP00000358532.3 | |||
| RBM20 | ENST00000718239.1 | c.3452-9C>G | intron_variant | Intron 12 of 13 | ENSP00000520684.1 | |||||
| RBM20 | ENST00000471172.1 | n.28-9C>G | intron_variant | Intron 1 of 1 | 5 | |||||
| RBM20 | ENST00000480343.2 | n.85-9C>G | intron_variant | Intron 1 of 2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0286 AC: 4344AN: 152134Hom.: 193 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4344
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00292 AC: 4073AN: 1396318Hom.: 218 Cov.: 30 AF XY: 0.00248 AC XY: 1710AN XY: 688160 show subpopulations
GnomAD4 exome
AF:
AC:
4073
AN:
1396318
Hom.:
Cov.:
30
AF XY:
AC XY:
1710
AN XY:
688160
show subpopulations
African (AFR)
AF:
AC:
3372
AN:
31534
American (AMR)
AF:
AC:
192
AN:
35620
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25124
East Asian (EAS)
AF:
AC:
0
AN:
35646
South Asian (SAS)
AF:
AC:
24
AN:
79064
European-Finnish (FIN)
AF:
AC:
0
AN:
49248
Middle Eastern (MID)
AF:
AC:
18
AN:
5684
European-Non Finnish (NFE)
AF:
AC:
83
AN:
1076584
Other (OTH)
AF:
AC:
384
AN:
57814
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
189
378
567
756
945
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0286 AC: 4360AN: 152252Hom.: 194 Cov.: 32 AF XY: 0.0275 AC XY: 2049AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
4360
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
2049
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
4142
AN:
41518
American (AMR)
AF:
AC:
151
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
4
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20
AN:
68018
Other (OTH)
AF:
AC:
42
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
197
394
592
789
986
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.